RealFeedApp beta

ImmunoBrain immunotherapy shows success in Alzheimer's treatment

ImmunoBrain presented early-stage data on a novel approach targeting the peripheral immune system to break the cycle between neuroinflammation and immune decline, showing efficacy beyond amyloid and tau targets.

Field
medicine and diagnostics
What they did
ImmunoBrain has generated early clinical data showing success for an immunotherapy approach that treats Alzheimer's by restoring the body's peripheral immune system, rather than just targeting amyloid plaques and tau tangles.
Why it matters
This could benefit patients with Alzheimer's and other neurodegenerative diseases by breaking the vicious cycle between brain inflammation and declining peripheral immune function.
#alzheimer's#immunotherapy#neuroinflammation#clinical trial

Read the original →